TXN2 and lung cancer: TXN2 overexpression or HP depletion decreased erastin and RSL‐induced lipid oxidation in lung cancer cell lines, which were shown by the green fluorescence intensity (levels of oxidized C11 BODIPY 581/591) (Figure 6H).